Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allopathic and complementary alternatives to hormone replacement therapy.

Amy C Eichholz1, Vikas Mahavni, Anil K Sood

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.

Expert Opinion on Pharmacotherapy
|June 27, 2002
PubMed
Summary

Women are living longer, spending more years in menopause. This review explores alternative therapies for menopause management beyond traditional estrogen replacement, focusing on individualized care and complementary medicine options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.

Clinical cancer research : an official journal of the American Association for Cancer Research·2018
Same author

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.

Therapeutic advances in medical oncology·2018
Same author

Stress effects on FosB and interleukin-8 (<i>IL8</i>)-driven ovarian cancer growth and metastasis.

The Journal of biological chemistry·2018
Same author

Stress, inflammation, and eicosanoids: an emerging perspective.

Cancer metastasis reviews·2018
Same author

Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.

Cancer·2018
Same author

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.

Drug delivery·2018

Area of Science:

  • Women's Health
  • Endocrinology
  • Gerontology

Background:

  • Increasing female lifespan leads to a larger proportion of life spent in menopause.
  • Optimal menopause management requires flexible, individualized strategies.
  • Traditional estrogen replacement therapy (ERT) has limitations and contraindications.

Purpose of the Study:

  • To review alternative menopause management therapies.
  • To explore options for women unable or unwilling to use ERT.
  • To cover both allopathic and complementary medicine approaches.

Main Methods:

  • Literature review of alternative menopause management strategies.
  • Analysis of current allopathic and complementary medicine options.
  • Synthesis of information on flexible and individualized care.

Related Experiment Videos

Main Results:

  • Growing interest in non-estrogen alternatives for menopause symptom management.
  • Integration of complementary medicine alongside conventional treatments.
  • Emphasis on patient-centered care and diverse therapeutic choices.

Conclusions:

  • Individualized approaches are key to effective menopause management.
  • Alternative therapies offer viable options for women seeking non-estrogen treatments.
  • A comprehensive review of alternatives supports informed decision-making for menopausal women.